Remove Hurdles to Cancer Care

Share

COVID-19 has shone a spotlight on the significant barriers to affordable health care that cancer patients have long faced. While relief packages and proposals to date have worked to address affordability of COVID-specific testing and treatment, policymakers must also tackle hurdles that cancer patients face like removing the red tape of prior authorization and step therapy, reducing out-of-pocket costs, and ensuring cost-sharing assistance directly benefits patients. There has been a great deal of research and investment in effective therapies that allow people fighting cancer to survive and live longer. Cancer patients need Congress to act quickly to remove hurdles to quality care.

56% of cancer patients and survivors are worried about being able to afford their treatment

Latest Updates

December 17, 2021
New York

ACS CAN looks forward to working with the new New York City Mayor and City Council Speaker on crucial health issues.

November 18, 2021
Ohio

COLUMBUS, OHIO – “Today, the Ohio House passed HB 218, which allows vague and subjective exemptions to vaccine requirements based on reasons of conscience. As an employer and advocate for cancer patients, the American Cancer Society (ACS) needs to be able to make decisions in the best interest of its

October 13, 2021
Ohio

COLUMBUS, OHIO – “Today, the Ohio House paused HB 435, which allows vague and subjective exemptions to vaccine mandates based on reasons of conscience. The American Cancer Society’s (ACS) right to make decisions in the best interest of their employees, the cancer patients they serve and the right of cancer

September 2, 2021
Idaho

This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever. But cancer remains a critical public health problem and getting new and affordable therapies from the research lab to the patient will require

Remove Hurdles to Cancer Care Resources

Most patients experience spikes in their health care costs around the time of a cancer diagnosis as they pay their deductible and out-of-pocket maximum. For patients on high deductible plans, this spike can mean bills due for several thousands of dollars within one month.

The U.S. spent approximately $183 billion on cancer-related health care in 2015. This represents a signification portion of the total health care spending in the U.S. And it is expected to keep growing. By 2030 cancer-related health care spending is expected to reach nearly $246 billion.

Many cancer patients take multiple drugs as part of their treatment – often for many months or years. While drugs are not the only costly part of cancer treatment, finding ways to reduce these costs for patients and payers will significantly reduce the overall cost burden of cancer.